Tag: Macular Degeneration
Age-Related Macular Degeneration Tied to Heightened Risk for Rheumatoid Arthritis
Findings seen after adjusting for lifestyle factors and comorbidities
Socioeconomic Factors Increase Risk for Age-Related Macular Degeneration
However, a healthy lifestyle can mitigate some of the risks associated with low socioeconomic status
Micronutrient Supplementation Slows Geographic Atrophy Progression
In eyes with noncentral GA, proximity-based progression toward central macula was slower with randomization to antioxidants
Melatonin Use Linked to Reduced Risk for Development, Progression of AMD
Melatonin use linked to reduced risk for developing AMD and for progression from nonexudative to exudative AMD
Home Vision Tests Offer Limited Diagnostic Accuracy for Neovascular AMD
Hospital eye service follow-up clinics maintain better diagnostic accuracy for active lesions
Outdoor Artificial Light at Night Tied to New Exudative AMD
Association found to be stronger with higher levels of exposure, but only significant in urban areas
FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
Two trials show significant slowing of geographic atrophy progression at the 12-month primary end point
Amsler Grid Not Sensitive Enough for Diagnosing Neovascular AMD
Sensitivity was 67 percent, specificity was 99 percent compared with healthy controls
FDA Approves First Treatment for Geographic Atrophy
Pegcetacoplan approved as an injection with dosing every 25 to 60 days
U.S. Adults Lack Knowledge About Age-Related Macular Degeneration
Gaps in knowledge for the leading cause of adult blindness seen for symptoms, treatment